Nurix Therapeutics reported cash from operations of -$96.57M and free cash flow of -$97.85M for the quarter ended May 2026, down 52.9% year over year. This cash flow statement covers 28 quarters of results from Aug 2019 through May 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Aug2019 | Nov2019 | Feb2020 | May2020 | Aug2020 | Nov2020 | Feb2021 | May2021 | Aug2021 | Nov2021 | Feb2022 | May2022 | Aug2022 | Nov2022 | Feb2023 | May2023 | Aug2023 | Nov2023 | Feb2024 | May2024 | Aug2024 | Nov2024 | Feb2025 | May2025 | Aug2025 | Nov2025 | Feb2026 | May2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||
| Net Income | -28.84M | -37.69M | -42.53M | -45.40M | -45.71M | -46.72M | -40.73M | -24.28M | -36.98M | -41.96M | -41.52M | -44.55M | -48.96M | -58.55M | -56.35M | -43.46M | -86.42M | -78.22M | -87.17M | -89.53M | ||||||||
| Share-based CompensationStock Comp. | 54.90M | 4.84M | 6.52M | 68.20M | 85.90M | 8.30M | 8.48M | 8.72M | 8.45M | 8.02M | 7.82M | 8.85M | 8.75M | 8.51M | 8.72M | 17.99M | 5.79M | 5.47M | 9.40M | 11.39M | ||||||||
| Cash from OperationsCash from Ops. | -29.97M | -30.91M | -42.63M | -32.91M | -46.31M | -37.95M | -48.45M | -18.47M | -41.13M | 26.69M | -41.95M | -39.70M | -42.18M | -48.75M | -61.09M | -63.16M | -57.38M | -67.83M | -71.91M | -96.57M | ||||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 0.86M | 0.85M | 1.26M | 1.35M | 1.43M | 1.42M | 1.43M | 1.44M | 1.43M | 1.82M | 1.93M | 2.16M | 3.71M | 3.49M | 3.56M | 2.70M | 2.20M | 1.87M | 1.98M | 1.56M | ||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 0.70M | 0.77M | 0.99M | 1.30M | 1.50M | 1.62M | 1.75M | 1.90M | 1.95M | 1.93M | 2.04M | 2.33M | 2.39M | 2.55M | 2.35M | 2.24M | 2.03M | 2.12M | 2.20M | 2.25M | ||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | 2.00M | -2.00M | ||||||||||||||||||||||||||
| Change in Account PayablesChange Payables | -1.39M | 0.86M | -0.10M | 1.85M | -0.76M | -0.90M | 0.40M | -2.24M | -1.20M | 4.65M | -0.93M | -2.54M | 1.09M | 7.58M | -3.21M | -2.68M | 2.23M | 3.02M | -0.46M | 1.87M | ||||||||
| Change in Accured ExpensesChange Accured Exp. | 3.53M | 3.38M | -3.32M | 6.14M | 1.36M | 3.30M | -6.91M | 2.26M | 4.70M | 3.08M | 3.59M | -6.84M | 6.04M | 9.02M | 6.94M | -7.01M | 6.34M | 11.04M | 4.12M | -15.25M | ||||||||
| Other Working Capital ChangesOther WC Changes | -9.25M | 3.60M | -3.62M | -9.43M | -9.29M | -4.28M | -9.18M | -5.68M | -16.47M | 50.84M | -12.59M | 4.91M | -7.59M | -13.28M | -9.83M | -5.68M | -7.89M | -13.58M | -1.25M | -7.04M | ||||||||
| Investing Activities | ||||||||||||||||||||||||||||
| Capital ExpendituresCapex | 1.86M | 0.86M | 3.47M | 2.79M | 3.42M | 2.56M | 2.28M | 1.08M | 2.46M | 2.58M | 2.88M | 1.94M | 2.35M | 2.10M | 3.48M | 2.67M | 2.71M | 5.13M | 1.70M | 1.28M | ||||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 64.21M | 55.02M | 58.75M | 62.81M | 72.77M | 84.48M | 40.99M | 105.62M | 99.82M | 76.61M | 93.20M | 95.98M | 110.83M | 159.50M | 139.20M | 142.34M | 156.19M | 179.81M | 133.15M | 119.56M | ||||||||
| Cash from Investing ActivitiesCash from Investing | -12.23M | -36.52M | 40.03M | -4.76M | -63.08M | 55.01M | 16.07M | 43.83M | 22.77M | -14.37M | 35.51M | -131.07M | -21.34M | -140.82M | 25.53M | 71.50M | 50.48M | 0.35M | -123.83M | 93.00M | ||||||||
| Financing Activities | ||||||||||||||||||||||||||||
| Other financing activitiesOther financing | 1.02M | 1.06M | -92.99M | 1.45M | 0.78M | 1.27M | 2.34M | -1.47M | 1.25M | 0.98M | 1.60M | |||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | 1.55M | 0.50M | 1.49M | 0.43M | 115.41M | -0.14M | 1.48M | 0.03M | 1.70M | 0.01M | 1.62M | 237.75M | 45.77M | 200.52M | 1.47M | 0.01M | 1.16M | 236.01M | 19.98M | 0.07M | ||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | 2.34M | 0.92M | ||||||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 50.20M | 42.90M | 95.40M | 18.00M | ||||||||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||
| Change in Cash | -40.65M | -66.93M | -1.11M | -37.25M | 6.02M | 16.92M | -30.90M | 25.39M | -16.65M | 12.32M | -4.81M | 66.98M | -17.75M | 10.95M | -34.08M | 8.34M | -5.75M | 168.52M | -175.76M | -3.51M | ||||||||
| Free Cash FlowFCF | -31.84M | -31.77M | -46.10M | -35.70M | -49.73M | -40.52M | -50.73M | -19.55M | -43.59M | 24.10M | -44.84M | -41.64M | -44.52M | -50.86M | -64.57M | -65.84M | -60.10M | -72.96M | -73.61M | -97.85M | ||||||||
| Net Cash FlowNCF | -40.65M | -66.93M | -1.11M | -37.25M | 6.02M | 16.92M | -30.90M | 25.39M | -16.65M | 12.32M | -4.81M | 66.98M | -17.75M | 10.95M | -34.08M | 8.34M | -5.75M | 168.52M | -175.76M | -3.51M |